Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 01/2017, Volume 45, Issue 1, pp. 160 - 168
Summary Background In HCV‐infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the...
STORM | METAANALYSIS | THERAPY | HEPATITIS-C VIRUS | CIRRHOSIS | PHARMACOLOGY & PHARMACY | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Follow-Up Studies | Hepatitis C - drug therapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Interferons - therapeutic use | Neoplasm Recurrence, Local - surgery | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Liver Neoplasms - drug therapy | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Neoplasm Recurrence, Local - diagnosis | Catheter Ablation - methods | Hepatitis C - diagnosis | Hepatitis C - surgery | Liver Neoplasms - diagnosis | Liver Cirrhosis - surgery | Aged | Care and treatment | Ablation (Surgery) | Usage | Relapse | Liver | Hepatoma | Biological response modifiers | Diseases | Analysis | Surgery | Interferon | Hepatitis C virus | Liver cirrhosis | Cirrhosis | Liver cancer | Antiviral agents | Documents | Hepatocellular carcinoma | Infections | Ablation | Patients | Cancer | Tumors
STORM | METAANALYSIS | THERAPY | HEPATITIS-C VIRUS | CIRRHOSIS | PHARMACOLOGY & PHARMACY | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Follow-Up Studies | Hepatitis C - drug therapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Interferons - therapeutic use | Neoplasm Recurrence, Local - surgery | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Liver Neoplasms - drug therapy | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Neoplasm Recurrence, Local - diagnosis | Catheter Ablation - methods | Hepatitis C - diagnosis | Hepatitis C - surgery | Liver Neoplasms - diagnosis | Liver Cirrhosis - surgery | Aged | Care and treatment | Ablation (Surgery) | Usage | Relapse | Liver | Hepatoma | Biological response modifiers | Diseases | Analysis | Surgery | Interferon | Hepatitis C virus | Liver cirrhosis | Cirrhosis | Liver cancer | Antiviral agents | Documents | Hepatocellular carcinoma | Infections | Ablation | Patients | Cancer | Tumors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 10541 - 10541
Journal Article
Liver International, ISSN 1478-3223, 08/2017, Volume 37, Issue 8, pp. 1157 - 1166
Background & Aims Determining risk for recurrence or survival after curative resection or ablation in patients with hepatitis C virus (HCV)‐related...
recurrences | prognosis | hepatocellular carcinoma | survival | OXIDATIVE STRESS | ANGIOGENESIS | RNA REPLICATION | LIVER-DISEASES | MECHANISMS | ANGIOPOIETIN-2 | CORE PROTEIN | NS5A PROTEIN INTERACTS | HEPATITIS-C VIRUS | ENDOTHELIAL-CELLS | GASTROENTEROLOGY & HEPATOLOGY | Liver Neoplasms - virology | Carcinoma, Hepatocellular - mortality | Humans | Hepatitis C - complications | Carcinoma, Hepatocellular - therapy | Carcinoma, Hepatocellular - virology | Liver Neoplasms - therapy | Neoplasm Recurrence, Local - epidemiology | Liver Neoplasms - mortality | Antiviral agents | Care and treatment | Ablation (Surgery) | Analysis | Mortality | Albumin | Hepatoma | Hepatitis C virus | Hepatitis C | Health aspects | Identification methods | Clinical trials | Viruses | Hepatocellular carcinoma | Serum albumin | Regression analysis | Risk analysis | α-Fetoprotein | Ablation | Patients | Survival | Studies | Hepatitis | Heterogeneity | Liver cancer | Randomization | Tumors
recurrences | prognosis | hepatocellular carcinoma | survival | OXIDATIVE STRESS | ANGIOGENESIS | RNA REPLICATION | LIVER-DISEASES | MECHANISMS | ANGIOPOIETIN-2 | CORE PROTEIN | NS5A PROTEIN INTERACTS | HEPATITIS-C VIRUS | ENDOTHELIAL-CELLS | GASTROENTEROLOGY & HEPATOLOGY | Liver Neoplasms - virology | Carcinoma, Hepatocellular - mortality | Humans | Hepatitis C - complications | Carcinoma, Hepatocellular - therapy | Carcinoma, Hepatocellular - virology | Liver Neoplasms - therapy | Neoplasm Recurrence, Local - epidemiology | Liver Neoplasms - mortality | Antiviral agents | Care and treatment | Ablation (Surgery) | Analysis | Mortality | Albumin | Hepatoma | Hepatitis C virus | Hepatitis C | Health aspects | Identification methods | Clinical trials | Viruses | Hepatocellular carcinoma | Serum albumin | Regression analysis | Risk analysis | α-Fetoprotein | Ablation | Patients | Survival | Studies | Hepatitis | Heterogeneity | Liver cancer | Randomization | Tumors
Journal Article
Liver International, ISSN 1478-3223, 02/2017, Volume 37, Issue 2, pp. 259 - 270
Background & Aims Epidemiology of hepatocellular carcinoma is changing worldwide. This study aimed at evaluating the changing scenario of aetiology,...
epidemiology | treatment | hepatocellular carcinoma | survival | EARLY-DIAGNOSIS | MANAGEMENT | FATTY LIVER-DISEASE | STAGE | ANNUAL SURVEILLANCE | CANCER | IMPACT | CIRRHOSIS | GASTROENTEROLOGY & HEPATOLOGY | PATIENT SURVIVAL | Carcinoma, Hepatocellular - epidemiology | Age Distribution | Prognosis | Humans | Middle Aged | Catheter Ablation | Male | alpha-Fetoproteins - analysis | Young Adult | Liver Neoplasms - epidemiology | Aged, 80 and over | Sex Distribution | Adult | Female | Italy - epidemiology | Aged | Retrospective Studies | Neoplasm Staging | Databases, Factual | Ablation (Surgery) | Hepatoma | Epidemiology | Analysis | Liver | Ethanol | Migration | Hepatocellular carcinoma | Patients | Survival | Ablation | Lead time | Radio frequency | Liver cancer | Surveillance | Medical prognosis | Aging | Tumors | Cancer
epidemiology | treatment | hepatocellular carcinoma | survival | EARLY-DIAGNOSIS | MANAGEMENT | FATTY LIVER-DISEASE | STAGE | ANNUAL SURVEILLANCE | CANCER | IMPACT | CIRRHOSIS | GASTROENTEROLOGY & HEPATOLOGY | PATIENT SURVIVAL | Carcinoma, Hepatocellular - epidemiology | Age Distribution | Prognosis | Humans | Middle Aged | Catheter Ablation | Male | alpha-Fetoproteins - analysis | Young Adult | Liver Neoplasms - epidemiology | Aged, 80 and over | Sex Distribution | Adult | Female | Italy - epidemiology | Aged | Retrospective Studies | Neoplasm Staging | Databases, Factual | Ablation (Surgery) | Hepatoma | Epidemiology | Analysis | Liver | Ethanol | Migration | Hepatocellular carcinoma | Patients | Survival | Ablation | Lead time | Radio frequency | Liver cancer | Surveillance | Medical prognosis | Aging | Tumors | Cancer
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.